Yong Xu

1.8k total citations
102 papers, 1.2k citations indexed

About

Yong Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yong Xu has authored 102 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Yong Xu's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers). Yong Xu is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers). Yong Xu collaborates with scholars based in China, United States and South Sudan. Yong Xu's co-authors include Lin Zhou, Xianmei Zhou, Di Han, You Lü, Fanchao Feng, Youling Gong, Meijuan Huang, Xiaojuan Zhou, Cheng Gu and Yongmei Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Yong Xu

91 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Xu China 19 550 337 212 178 139 102 1.2k
Tetsuya Kawata Japan 19 347 0.6× 149 0.4× 356 1.7× 82 0.5× 90 0.6× 56 1.2k
Jiandong Zhang China 17 343 0.6× 258 0.8× 424 2.0× 52 0.3× 60 0.4× 79 1.1k
Naoki Sano Japan 13 440 0.8× 237 0.7× 103 0.5× 58 0.3× 361 2.6× 61 933
Jing Cui China 20 188 0.3× 237 0.7× 412 1.9× 83 0.5× 75 0.5× 70 1.2k
Koichiro Abe Japan 23 441 0.8× 198 0.6× 197 0.9× 115 0.6× 56 0.4× 92 1.7k
Yanling Wang China 15 382 0.7× 144 0.4× 319 1.5× 83 0.5× 26 0.2× 64 1.1k
Jianhua Xu China 21 222 0.4× 274 0.8× 389 1.8× 75 0.4× 32 0.2× 94 1.2k
Carryn M. Anderson United States 18 322 0.6× 227 0.7× 227 1.1× 74 0.4× 61 0.4× 65 1.1k
Yohannes T. Ghebre United States 14 374 0.7× 125 0.4× 288 1.4× 39 0.2× 48 0.3× 21 954

Countries citing papers authored by Yong Xu

Since Specialization
Citations

This map shows the geographic impact of Yong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Xu more than expected).

Fields of papers citing papers by Yong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Xu. The network helps show where Yong Xu may publish in the future.

Co-authorship network of co-authors of Yong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Xu. A scholar is included among the top collaborators of Yong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Xu. Yong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Le, Qi Zhao, Dongwei Zhu, et al.. (2025). Nobiletin's role in idiopathic pulmonary fibrosis via the PI3K/AKT/MDM2/p53 signaling pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 399(1). 225–242.
2.
3.
Zhang, Yi, Zheng Li, Ying Huang, Bingwen Zou, & Yong Xu. (2024). Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis. BMJ Open. 14(1). e073887–e073887. 2 indexed citations
4.
Qu, Lin, et al.. (2024). Anti-tumor activity of butorphanol in colorectal cancer via targeting SIGMAR1. Discover Oncology. 15(1). 711–711. 1 indexed citations
5.
6.
7.
8.
Huang, Jingyi, et al.. (2023). Association of body mass index with mortality of sepsis or septic shock: an updated meta-analysis. Journal of Intensive Care. 11(1). 27–27. 19 indexed citations
9.
Xu, Yong, Di Han, Zhichao Wang, et al.. (2021). Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Technology. Evidence-based Complementary and Alternative Medicine. 2021. 1–11. 6 indexed citations
10.
Xu, Yong, Fanchao Feng, Cheng Gu, et al.. (2021). Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC. Evidence-based Complementary and Alternative Medicine. 2021. 1–18. 7 indexed citations
11.
Yang, Shuang, Yong Xu, Di Han, et al.. (2021). Chinese herbal medicine for symptoms of depression and anxiety in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice. 45. 101470–101470. 5 indexed citations
12.
Gu, Cheng, et al.. (2020). Suhuang Zhike Capsules for the Treatment of Cough Variant Asthma: A Meta‐analysis. Evidence-based Complementary and Alternative Medicine. 2020(1). 9485746–9485746. 6 indexed citations
13.
Chen, Xinyue, et al.. (2020). Inhibitory effects of alkaline extract from the pericarp of Citrus reticulata Blanco on collagen behavior in bleomycin-induced pulmonary fibrosis. Journal of Ethnopharmacology. 269. 113761–113761. 14 indexed citations
14.
Xu, Yong, et al.. (2020). Mechanism of Jinhua Qinggan Granules on COVID-19 based on network pharmacology and molecular docking. Tianran chanwu yanjiu yu kaifa. 32(12). 1992. 2 indexed citations
15.
Feng, Fanchao, Qi Wu, Yihan Jin, et al.. (2019). Disodium Cantharidinate and Vitamin B6 Injection Adjunct with Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 7 indexed citations
16.
Yu, Min, Qian Zhao, Yanying Li, et al.. (2018). Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor. Cancer Biotherapy and Radiopharmaceuticals. 33(10). 421–426. 6 indexed citations
17.
Zou, Bingwen, Tao Li, Daiyuan Ma, et al.. (2016). Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients. Medicine. 95(17). e3507–e3507. 18 indexed citations
18.
19.
20.
Li, Zhiping, Xiaomei Chen, Xiaojing Liu, et al.. (2008). [Correlation study of physical and biologic parameters to acute radiation pneumonitis].. PubMed. 39(5). 796–800. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuya Kawata Breakdown of academic impact, for papers by Jiandong Zhang Breakdown of academic impact, for papers by Naoki Sano Breakdown of academic impact, for papers by Jing Cui Breakdown of academic impact, for papers by Koichiro Abe Breakdown of academic impact, for papers by Yanling Wang Breakdown of academic impact, for papers by Jianhua Xu Breakdown of academic impact, for papers by Carryn M. Anderson Breakdown of academic impact, for papers by Yohannes T. Ghebre
Rankless by CCL
2026